beta
PRTO
Proteon Therapeutics, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.
Market Cap: 14.4 Million
Primary Exchange: NASDAQ
Website: http://www.proteontherapeutics.com
Shares Outstanding: 22.2 Million
Float: 11.6 Million
Dividend: (%)
Beta: 0.716191598192449
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1193 trading days
From: 2015-07-17 To: 2020-01-08
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|